Sign in Subscribe

Veeva Systems (VEEV) Q4 FY1/2025 Earnings Review

Last updated on 
  • Veeva posted yet another strong quarter, delivering financial results ahead of guidance.
  • The Vault CRM implementation is on track, and the AI strategy is crystallizing more definitively in the form of products.
  • Technically, the stock might be undergoing an a-b-c correction. It will need to break out of the upward-trending channel to reach higher levels.
  • Read on for a detailed financial and technical analysis.

DISCLAIMER: This note is intended for US recipients only and, in particular, is not directed at, nor intended to be relied upon by any UK recipients. Any information or analysis in this note is not an offer to sell or the solicitation of an offer to buy any securities. Nothing in this note is intended to be investment advice and nor should it be relied upon to make investment decisions. Cestrian Capital Research, Inc., its employees, agents or affiliates, including the author of this note, or related persons, may have a position in any stocks, security, or financial instrument referenced in this note. Any opinions, analyses, or probabilities expressed in this note are those of the author as of the note's date of publication and are subject to change without notice. Companies referenced in this note or their employees or affiliates may be customers of Cestrian Capital Research, Inc. Cestrian Capital Research, Inc. values both its independence and transparency and does not believe that this presents a material potential conflict of interest or impacts the content of its research or publications.

Another Good Quarter

By Abhishek Singh (Abhisingh_86)

Veeva posted yet another strong quarter, delivering financial results ahead of guidance. Here are the headline numbers:

  • Trailing Twelve Months (TTM) revenue growth remained stable at 16%.
  • TTM EBITDA margins increased to 43%, while TTM cash flow margins declined by 100 basis points to 42%.
  • Strong balance sheet with $5.2 billion in cash.
Source: Company SEC Filings, YCharts.com and Cestrian Analysis

Key Business Updates

Veeva continues to drive digital transformation in the pharma/biotech industry with strong growth, product adoption, and AI innovation across all segments. Here is a concise summary of recent business updates:

  • Development Cloud: Strong adoption among top biopharma companies, with a major firm committing to Veeva’s full clinical platform. Safety solutions are also gaining traction, positioning Veeva for AI-driven innovation.
  • Quality Cloud: 41 new customers, with growing interest in newer products like Validation Management and LIMS.
  • Commercial Cloud: Vault CRM expansion continues, adding 20 new customers. Crossix analytics saw major adoption by a top 20 biopharma company.
  • Data Cloud: Veeva Link Key People is now an industry standard, while Compass has surpassed 100 brands. The company also launched CRM Pulse, a unique data asset available in 21 countries.

I’d like to highlight three specific aspects in more detail:

1. Vault CRM Implementation